{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:52:37Z","timestamp":1774475557225,"version":"3.50.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.ecl.2005.01.014","type":"journal-article","created":{"date-parts":[[2005,4,24]],"date-time":"2005-04-24T07:16:06Z","timestamp":1114326966000},"page":"341-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Osteoporosis Associated with Excess Glucocorticoids"],"prefix":"10.1016","volume":"34","author":[{"given":"Joseph L.","family":"Shaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara P.","family":"Lukert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ecl.2005.01.014_bib1","first-page":"137","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)","volume":"1","author":"Cushing","year":"1932","journal-title":"Bull Johns Hopkins Hosp"},{"issue":"1","key":"10.1016\/j.ecl.2005.01.014_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bjs.1800580102","article-title":"The natural history of treated Cushing's syndrome","volume":"58","author":"Welbourn","year":"1971","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ecl.2005.01.014_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0889-8529(18)30340-2","article-title":"Corticosteroid-induced osteoporosis","volume":"19","author":"Hodgson","year":"1990","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ecl.2005.01.014_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.0300-0664.2001.01454.doc.x","article-title":"Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease","volume":"56","author":"Di Somma","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2005.01.014_bib5","first-page":"1863","article-title":"Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome","volume":"83","author":"Chiodini","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.01.014_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/eje.0.1460051","article-title":"Increased risk of osteoporotic fractures in patients with Cushing's syndrome","volume":"146","author":"Vestergaard","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ecl.2005.01.014_bib7","first-page":"132","article-title":"Occult Cushing's syndrome presenting with osteoporosis","volume":"28","author":"Kleerekoper","year":"1980","journal-title":"Henry Ford Hosp Med J"},{"key":"10.1016\/j.ecl.2005.01.014_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1507\/endocrj.50.1","article-title":"Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome","volume":"50","author":"Ohmori","year":"2003","journal-title":"Endocr J"},{"key":"10.1016\/j.ecl.2005.01.014_bib9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00198-004-1616-3","article-title":"Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome","volume":"15","author":"Minetto","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2005.01.014_bib10","first-page":"3303","article-title":"Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas","volume":"82","author":"Osella","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.01.014_bib11","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1210\/jcem.84.7.5856","article-title":"Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism","volume":"84","author":"Torlontano","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.01.014_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1365-2265.2003.01676.x","article-title":"Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?","volume":"58","author":"Hadjidakis","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2005.01.014_bib13","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1210\/jc.2002-020399","article-title":"Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism","volume":"87","author":"Chiodini","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2005.01.014_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1385\/BMM:2:2:079","article-title":"Glucocorticoid-induced osteoporosis","volume":"2","author":"Graves","year":"2004","journal-title":"Clinical Reviews in Bone and Mineral Metabolism"},{"key":"10.1016\/j.ecl.2005.01.014_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1359\/jbmr.2001.16.1.97","article-title":"Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis","volume":"16","author":"Carbonare","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00675619","article-title":"Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content","volume":"52","author":"Laan","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ecl.2005.01.014_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","article-title":"Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis","volume":"119","author":"Laan","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198308043090502","article-title":"Steroid-induced fractures and bone loss in patients with asthma","volume":"309","author":"Adinoff","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","article-title":"A meta-analysis of prior corticosteroid use and fracture risk","volume":"19","author":"Kanis","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1359\/jbmr.2003.18.5.913","article-title":"Children and the risk of fractures caused by oral corticosteroids","volume":"18","author":"Van Staa","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.ecl.2005.01.014_bib22","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","article-title":"Risedronate therapy prevents corticosteroid-induced bone loss","volume":"42","author":"Cohen","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ecl.2005.01.014_bib23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/thx.46.11.803","article-title":"Vertebral fractures in steroid-dependent asthma and involutional osteoporosis: a comparative study","volume":"46","author":"Luengo","year":"1991","journal-title":"Thorax"},{"key":"10.1016\/j.ecl.2005.01.014_bib24","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1359\/jbmr.2000.15.5.952","article-title":"Corticosteroids do not alter the threshold for vertebral fracture","volume":"15","author":"Selby","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib25","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","article-title":"Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy","volume":"48","author":"Van Staa","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2005.01.014_bib26","first-page":"1114","article-title":"Screening and treatment of glucocorticoid induced osteoporosis among 6517 adults","volume":"19","author":"Curtis","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/bmj.302.6777.627","article-title":"Beclomethasone inhalation decreases serum osteocalcin concentrations","volume":"302","author":"Pouw","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.ecl.2005.01.014_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/8756-3282(92)90072-5","article-title":"Inhaled beclomethasone decreases serum osteocalcin in postmenopausal asthmatic women","volume":"13","author":"Poulijoki","year":"1992","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2005.01.014_bib29","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1046\/j.1365-2222.1998.00358.x","article-title":"Bone mineral density and body composition in patients with airflow obstruction\u2013the role of inhaled steroid therapy, disease and lifestyle","volume":"28","author":"Lau","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.ecl.2005.01.014_bib30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(00)02138-3","article-title":"Inhaled corticosteroid use and bone mineral density in patients with asthma","volume":"355","author":"Wong","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2005.01.014_bib31","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1359\/jbmr.2001.16.4.782","article-title":"Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women","volume":"16","author":"Fujita","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib32","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa002304","article-title":"Effects of inhaled glucocorticoids on bone density in premenopausal women","volume":"345","author":"Israel","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4065\/79.4.458","article-title":"Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial","volume":"79","author":"Kemp","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ecl.2005.01.014_bib34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.2001.16.3.581","article-title":"Use of inhaled corticosteroids and risk of fractures","volume":"16","author":"Van Staa","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib35","doi-asserted-by":"crossref","first-page":"648","DOI":"10.7326\/0003-4819-104-5-648","article-title":"Reduction of serum testosterone levels during chronic glucocorticoid therapy","volume":"104","author":"MacAdams","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib36","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1053\/meta.2002.35583","article-title":"Low circulating estradiol and adrenal androgens concentrations in men on glucocorticoids. a potential contributory factor in steroid-induced osteoporosis","volume":"51","author":"Hampson","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.ecl.2005.01.014_bib37","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.ecl.2005.01.014_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02563820","article-title":"Malabsorption of calcium in corticosteroid-induced osteoporosis","volume":"46","author":"Morris","year":"1990","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ecl.2005.01.014_bib39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000180820","article-title":"Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics","volume":"27","author":"Reid","year":"1987","journal-title":"Horm Res"},{"issue":"9","key":"10.1016\/j.ecl.2005.01.014_bib40","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1210\/jc.2002-012101","article-title":"The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence","volume":"87","author":"Rubin","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2005.01.014_bib41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ecl.2005.01.014_bib42","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1210\/jc.2004-0164","article-title":"Immediate fall of bone formation and transient increase in bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis","volume":"89","author":"Dovio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.01.014_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1749-6632.2002.tb04204.x","article-title":"Mechanisms of glucocorticoid action in bone","volume":"966","author":"Canalis","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ecl.2005.01.014_bib44","first-page":"4490","article-title":"Glucocorticoid regulation of transforming growth factor \u03b21 activity and binding in osteoblast-enriched cultures from fetal rat bone","volume":"11","author":"Centrella","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ecl.2005.01.014_bib45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbrc.2004.04.025","article-title":"Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis","volume":"318","author":"Ohnaka","year":"2004","journal-title":"Biochem Biophys Res Com"},{"issue":"6","key":"10.1016\/j.ecl.2005.01.014_bib46","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1359\/jbmr.2002.17.6.979","article-title":"Osteoblastic 11\u03b2-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure","volume":"17","author":"Cooper","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib47","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1359\/jbmr.2001.16.6.1037","article-title":"Modulation of 11 beta-hydroxysteroid dehydrogenase isoenzymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation","volume":"17","author":"Cooper","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/0003-4819-107-2-319","article-title":"Recovery from steroid-induced osteoporosis","volume":"107","author":"Pocock","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib49","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0002-9343(88)80048-2","article-title":"Reversibility of steroid-induced osteoporosis","volume":"85","author":"Lufkin","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2265.1992.tb01437.x","article-title":"Normal bone mineral density following cure of Cushing's syndrome","volume":"36","author":"Manning","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2005.01.014_bib51","first-page":"2859","article-title":"Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome","volume":"80","author":"Hermus","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.01.014_bib52","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2796.1996.416763000.x","article-title":"Recovery from severe osteoporosis following cure from ectopic ACTH syndrome caused by an appendix carcinoid","volume":"239","author":"Dobnig","year":"1996","journal-title":"J Intern Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib53","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2265.2003.01713.x","article-title":"Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study","volume":"58","author":"Di Somma","year":"2003","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.ecl.2005.01.014_bib54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00128071-200102060-00004","article-title":"Relationship between systemic corticosteroids and osteonecrosis","volume":"2","author":"Gebhard","year":"2001","journal-title":"American Journal of Clinical Dermatology"},{"issue":"2","key":"10.1016\/j.ecl.2005.01.014_bib55","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0889-8529(05)70017-7","article-title":"The science and therapy of glucocorticoid-induced bone loss","volume":"27","author":"Lane","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"8538","key":"10.1016\/j.ecl.2005.01.014_bib56","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(87)92870-4","article-title":"A cross-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone","volume":"1","author":"Felson","year":"1987","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.ecl.2005.01.014_bib57","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1056\/NEJM199205283262206","article-title":"Nontraumatic necrosis of bone (osteonecrosis)","volume":"326","author":"Mankin","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib58","first-page":"2907","article-title":"Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip","volume":"85","author":"Weinstein","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"386","key":"10.1016\/j.ecl.2005.01.014_bib59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00003086-200105000-00022","article-title":"Statin therapy decreases the risk of osteonecrosis in patients receiving steroids","volume":"1","author":"Pritchett","year":"2001","journal-title":"Clinical Orthopedics and Related Research"},{"issue":"5","key":"10.1016\/j.ecl.2005.01.014_bib60","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2106\/00004623-200205000-00023","article-title":"Osteonecrosis of the hip: management in the twenty-first century","volume":"84-A","author":"Lieberman","year":"2002","journal-title":"J Bone Joint Surg"},{"key":"10.1016\/j.ecl.2005.01.014_bib61","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5","article-title":"Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"44","author":"American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ecl.2005.01.014_bib62","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/1529-0131(199908)42:8<1740::AID-ANR25>3.0.CO;2-E","article-title":"The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach","volume":"42","author":"Amin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ecl.2005.01.014_bib63","doi-asserted-by":"crossref","first-page":"961","DOI":"10.7326\/0003-4819-125-12-199612150-00004","article-title":"Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis","volume":"125","author":"Buckley","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib64","first-page":"995","article-title":"Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3-year follow-up","volume":"23","author":"Adachi","year":"1996","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.ecl.2005.01.014_bib65","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1359\/jbmr.2002.17.8.1512","article-title":"The comparative efficacy of drug therapies used for the management of corticosteroid-induced osteoporosis: a meta-regression","volume":"17","author":"Amin","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib66","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJM199306173282404","article-title":"Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitonin","volume":"328","author":"Sambrook","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib67","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S8756-3282(98)00097-0","article-title":"Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men","volume":"23","author":"Gram","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.ecl.2005.01.014_bib68","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s001980050118","article-title":"Prophylactic use of alfacalcidiol in corticosteroid-induced osteoporosis","volume":"9","author":"Reginster","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2005.01.014_bib69","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1359\/jbmr.2003.18.5.919","article-title":"Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium","volume":"18","author":"Sambrook","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib70","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7326\/0003-4819-133-7-200010030-00010","article-title":"Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults; a randomized, double-blind, placebo-controlled trial","volume":"133","author":"LaCroix","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib71","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jbmr.5650100115","article-title":"Thiazide diuretics and fractures: can meta-analysis help?","volume":"10","author":"Jones","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib72","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/archinte.1996.00440100065008","article-title":"Testosterone therapy in glucocorticoid-treated men","volume":"156","author":"Reid","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib73","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1210\/jc.2002-021827","article-title":"Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment","volume":"88","author":"Crawford","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ecl.2005.01.014_bib74","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/jbmr.5650070909","article-title":"Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss","volume":"7","author":"Lukert","year":"1992","journal-title":"J Bone Min Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib75","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/art.1780371014","article-title":"Effect of hormone replacement therapy on bone mass in rheumatoid arthritis with and without steroids","volume":"37","author":"Hall","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ecl.2005.01.014_bib76","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women","volume":"282","author":"Writing Group for the Womens Health Initiative Investigators","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2005.01.014_bib77","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction in vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year, randomized clinical trial. Multiple outcome of Raloxifene (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2005.01.014_bib78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00610377","article-title":"Salmon calcitonin in the therapy of corticoid-induced osteoporosis","volume":"33","author":"Ringe","year":"1987","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ecl.2005.01.014_bib79","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02529727","article-title":"A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica","volume":"58","author":"Healey","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ecl.2005.01.014_bib80","first-page":"1875","article-title":"Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy?","volume":"23","author":"Kotaniemi","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ecl.2005.01.014_bib81","first-page":"1922","article-title":"Intermittent cyclic therapy with etidronate in the prevention of corticosteroid-induced bone loss","volume":"21","author":"Adachi","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ecl.2005.01.014_bib82","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0002-9343(99)80154-5","article-title":"Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis","volume":"99","author":"Struys","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib83","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","article-title":"Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis","volume":"337","author":"Adachi","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib84","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/ard.57.12.724","article-title":"Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double-blind, randomized placebo-controlled study","volume":"57","author":"Geusens","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ecl.2005.01.014_bib85","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/03009749950154211","article-title":"The prevention of corticosteroid-induced bone loss with intermittent cyclical etidronate","volume":"28","author":"Jenkins","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.ecl.2005.01.014_bib86","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1210\/jcem.83.4.4742","article-title":"Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss","volume":"83","author":"Roux","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2005.01.014_bib87","first-page":"2424","article-title":"A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss","volume":"27","author":"Adachi","year":"2000","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.ecl.2005.01.014_bib88","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ecl.2005.01.014_bib89","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W","article-title":"Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids","volume":"44","author":"Adachi","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ecl.2005.01.014_bib90","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1359\/jbmr.2000.15.4.754","article-title":"Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies","volume":"15","author":"Chavassieux","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib91","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002230001146","article-title":"Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy","volume":"67","author":"Wallach","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ecl.2005.01.014_bib92","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","article-title":"Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial","volume":"15","author":"Reid","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib93","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1359\/jbmr.2001.16.1.104","article-title":"Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone","volume":"16","author":"Boutsen","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib94","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002239900334","article-title":"Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial","volume":"61","author":"Boutsen","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ecl.2005.01.014_bib95","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00198-003-1425-0","article-title":"Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study","volume":"14","author":"Ringe","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2005.01.014_bib96","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI3914","article-title":"Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis","volume":"102","author":"Lane","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ecl.2005.01.014_bib97","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1359\/jbmr.2000.15.5.944","article-title":"Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial","volume":"15","author":"Lane","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ecl.2005.01.014_bib98","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00198-002-1312-0","article-title":"Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis","volume":"14","author":"Rehman","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2005.01.014_bib99","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/BF02652565","article-title":"Effect of sodium fluoride in the prevention of corticosteroid-induced osteoporosis","volume":"7","author":"Lems","year":"1997","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ecl.2005.01.014_bib100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/ard.56.6.357","article-title":"Is addition of fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis?","volume":"56","author":"Lems","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ecl.2005.01.014_bib101","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJM199003223221203","article-title":"Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis","volume":"322","author":"Riggs","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2005.01.014_bib102","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fractures in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852905000150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852905000150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:21:38Z","timestamp":1760174498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852905000150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0889852905000150"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2005.01.014","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoporosis Associated with Excess Glucocorticoids","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2005.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}